observed pharmacodynamic changes contributing to resistance against AMPs pexiganan and melittin, involving mutations in these genes.[172] Gomes et al.[182] found that pexiganan required higher concentrations to inhibit and kill co‐infections of S. aureus and P. aeruginosa compared to single‐species infections. Here, ADSL is linked to coinfection.